KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Assets: 2018-2025

Historic Assets for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $641.9 million.

  • Twist Bioscience's Assets rose 4.48% to $641.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $641.9 million, marking a year-over-year increase of 4.48%. This contributed to the annual value of $641.9 million for FY2025, which is 4.48% up from last year.
  • As of FY2025, Twist Bioscience's Assets stood at $641.9 million, which was up 4.48% from $614.3 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Assets ranged from a high of $961.4 million in FY2022 and a low of $614.3 million during FY2024.
  • Its 3-year average for Assets is $677.5 million, with a median of $641.9 million in 2025.
  • In the last 5 years, Twist Bioscience's Assets spiked by 76.02% in 2021 and then dropped by 20.88% in 2024.
  • Twist Bioscience's Assets (Yearly) stood at $702.1 million in 2021, then spiked by 36.93% to $961.4 million in 2022, then decreased by 19.24% to $776.4 million in 2023, then dropped by 20.88% to $614.3 million in 2024, then climbed by 4.48% to $641.9 million in 2025.